All In Biotech

Free tool

FAERS Monitor: Claritin Reditabs

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021993 or its brand name (Claritin Reditabs, Loratadine). Reports on generic versions are filed under their own applications.

Reports

104,790

Serious

49,542

47% of reports

Hospitalization

23,065

Death reported

4,558

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective12,371
  • fatigue6,616
  • nausea5,815
  • headache5,349
  • diarrhoea4,809
  • dyspnoea4,809
  • off label use4,642
  • dizziness4,320
  • pain4,066
  • rash3,439
  • pruritus3,375
  • cough3,094
  • vomiting2,963
  • arthralgia2,904
  • somnolence2,866

Reports by year received

View as table
YearReports
2004966
20051,079
20061,075
2007947
20081,078
20091,328
20101,645
20112,034
20123,276
20134,246
20144,999
20157,321
20168,813
20178,781
20187,751
20197,831
20207,033
20216,297
20226,122
20235,516
20246,029
20255,967
20264,655

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,949,369 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
somnolenceSignal2,8662.92.83,508
coughSignal3,0942.22.22,098
drug ineffective12,3711.91.95,501
pruritus3,3751.81.71,139
dizziness4,3201.71.71,394
headache5,3491.71.71,642
fatigue6,6161.71.72,015
dyspnoea4,8091.71.71,447
rash3,4391.61.5758
diarrhoea4,8091.51.5818
nausea5,8151.51.4927
arthralgia2,9041.41.4343
pain4,0661.31.3342
vomiting2,9631.31.2169
off label use4,6421.11.019

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.